Skip to main content

Table 2 Patients’ continuation of fibromyalgia treatment a

From: Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia

 

Amitriptyline

Pregabalin

Duloxetine

Pregabalin

Gabapentin

Pregabalin

Number of patients

8,269

8,269

9,941

9,941

18,613

18,613

Treatment duration

      
 

0 to 90 days

80.9

79.7

63.5

78.6

78.1

75.7

 

91 to 180 days

11.2

12.4

20.0

13.0

13.0

14.3

 

181 to 270 days

3.4

4.1

7.6

4.2

4.2

4.9

 

271 to 365 days

2.1

1.7

4.0

1.7

2.1

2.2

 

Over 365 days

2.4

1.2

4.9

2.5

2.7

2.8

PDC up to 180 days

38.6 ± 30.1

50.0 ± 31.2

55.0 ± 34.0

67.8 ± 33.4

45.0 ± 32.5

55.4 ± 32.4

  1. aPDC, Proportion of days covered. Data are percentage or mean ± SD.